Business · 28/11/2012Updated: 10/17/2026 · 1 min read
FDA to Hold Public Hearing on Nicotine Replacement Therapies and Smoking-Cessation Products
Summary
The FDA is requesting public input on the regulation of nicotine replacement therapies and smoking-cessation products, as part of a broader report to Congress on innovative products and treatments for tobacco dependence.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →